In Conversation

Having a Latin American dimension, not only in the business but also in management, is a catalyst for sustainability

Despite the projected GDP growth since 2020 in most of [LatAm], existing healthcare budgets and reforms are no longer adept at addressing the unmet needs, creating…

[The dengue vaccine] is a momentous achievement for Takeda and will have a big impact on LatAm, which – along with Asia – is home to…

Empathetic dialogue and an understanding of our shared goals, and the value that innovation brings to health systems are critical, as is facilitating enabling infrastructure, creating…

 Latin America is a critical region and part of the emerging markets that can contribute to business growth, but also offer talent and diversity.

With many new governments in the region, we also expect to see changes to the healthcare environment in many of our countries.

We could accelerate knowledge, save more children, and position drugs for more indications if we were able to conduct research [in Latin America]

PharmaBoardroom spoke to Fabrice Chouraqui, President of Novartis Latin America and Canada at the Financial Times LatAm Healthcare & Life Sciences Summit in September 2015. He…

The national coordinator of Plan Nacer and Plan Sumar – two social security programs to improve access to healthcare in Argentina – discusses universal coverage as a…

A senior director for Icon plc discusses Argentina’s strengths and weaknesses as a venue for clinical trials, the role the market plays in a global clinical…

Dr. Wanda Dobrzanski discusses Argentina’s potential and attractiveness as a clinical research environment and the biggest challenges facing local and global CROs in Argentina.

Gador’s first general director from outside of the family discusses his mission, Gador’s key to success, and his method for successfully leading a company in Argentina’s…

We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here